Amgen's Bone-Loss Drug Faces Marketing Thesis

PAGES
1
WORDS
492
Cite
Related Topics:

Yahoo has just announced that it will be spending $100 million on a new ad campaign and political candidates spent hundreds of millions on advertising in the recent presidentail election. So, marketing in the biotechnology is not really different from other industries. The terminology and players may be different, the basic fundamental marketing principles are the same. A company has to have value-based pricing, not pricing based on costs. and, companies must respond to negative statements about their products as well as spend huge amounts of money on advertising to win mind share.

Questions:

What are the differences between effective marketing strategies in biotechnology and other industries? Is the pricing strategy for biotechnology products different from other products?

Why Important:

It is essential to apply best-practice marketing principles and methods...

...

However, the uniqueness of biotechnology could require modification to this industry's requirements.
How to obtain:

I would obtain the answer to the first question by conducting research on the marketing issues confronting biotechnology companies and then researching other industries to determine if there are similar situations. To answer the second question, I would review drug prices for competitive drugs to help determine what the market is willing to pay.

Bibliography

Robinson, J.C. (2006, October 23). Biotech: Value-based pricing in biotechnology. Health Affairs. http://healthaffairs.org/blog/2006/10/23/biotech-value-based-pricing-in-biotechnology/

Weintraud, a. (2009, Auust 13, 2009). Amgen's bone-loss drug faces marketing hurdles. BusinessWeek. http://www.businessweek.com/magazine/content/09_34/b4144034804527.htm

Sources Used in Documents:

Bibliography

Robinson, J.C. (2006, October 23). Biotech: Value-based pricing in biotechnology. Health Affairs. http://healthaffairs.org/blog/2006/10/23/biotech-value-based-pricing-in-biotechnology/

Weintraud, a. (2009, Auust 13, 2009). Amgen's bone-loss drug faces marketing hurdles. BusinessWeek. http://www.businessweek.com/magazine/content/09_34/b4144034804527.htm


Cite this Document:

"Amgen's Bone-Loss Drug Faces Marketing" (2009, October 20) Retrieved April 25, 2024, from
https://www.paperdue.com/essay/amgen-bone-loss-drug-faces-marketing-18446

"Amgen's Bone-Loss Drug Faces Marketing" 20 October 2009. Web.25 April. 2024. <
https://www.paperdue.com/essay/amgen-bone-loss-drug-faces-marketing-18446>

"Amgen's Bone-Loss Drug Faces Marketing", 20 October 2009, Accessed.25 April. 2024,
https://www.paperdue.com/essay/amgen-bone-loss-drug-faces-marketing-18446

Related Documents

The extent of this collaboration between them was shown to be a powerful predictor of the firm's ultimate success along with products in development, products on the market and the number of people it employed (Hand). Forecast and Conclusion - Biotech promises to feed the world, reduce environmental harm, expand agricultural markets and production possibilities and create products consumers want (Shoemaker et al. 2003). Farmers seemed to trust and accept

PK = Deltagen Inc. PRXL = Parexel International Corp. Pvt1 = Quintiles Transnational Corp. (privately held) Industry = Biotechnology As of 2005 Source: Yahoo! Finance, April 29, 2007. Figure 1. Financial Performance: Charles River Laboratories vs. Deltagen Inc. And Parexel International Corp. - January 2002 to date. Source: Yahoo! Finance, April 29, 2007. Operating income for 2006 was reported by the company to be $188.2 million compared to $184.7 million for 2005 and its operating margin for 2006

The most dangerous of these practices is the use throughout the European Union (EU) to grow crops and raise livestock using Genetically Modified Organisms (GMO) (Johnson, 62, 63). To date there is little longitudinal analysis of the long-term effects of these foods on humans. GMO-based crops and livestock are also altering the economic structure of the EU's economies as well. The use of biotechnology to also change the intelligence

Biotechnology The Origins of Biotechnology For centuries, humans have been selectively breeding different plants and animals in an attempt to create a species more useful to human endeavors. This alteration of the fundamental basis of a species, although performed for most of human history, has only recently been understood in a more comprehensive manner. The origin of modern genetics can be traced to a little known European monk named Gregor Mendel, who,

Against a Radiologist Underlines the Need for Fully Informed Consent From Patients Do you agree with the court's decision? Why or why not? If the diagnosis had been made, the surgeon that did perform the procedure on Mrs. Paul would have been able to take appropriate precautions or would have decided not to have performed the surgery. Another option may have been to have postponed the surgery until the aneurysm was

Biotechnology Exploring the Pros and Cons of Biotechnology In a world of rapidly developing technology, there are growing concerns regarding just how far it will impact out lives. Biotechnology is the newest trend in agriculture and food production. It features genetically modified plants and animal proteins that haven altered to suit some man made need. Many claim this will help sustainability efforts. However, the true nature of GMOs does show danger I